Women's Health Screenings: Pap Smear, Mammogram, Bone Density, and...
Preventive health screenings are one of the most powerful tools available for maintaining women’s health. Regular screening tests can detect disease at early, treatable stages, reduce mortality, and in some cases prevent disease entirely through identification and management of precursor conditions. Yet screening uptake varies widely — while mammography rates have improved significantly, only about 65 percent of eligible women are up to date with cervical cancer screening, and osteoporosis screening rates remain below 30 percent in eligible women.
Screening recommendations are based on age, risk factors, and sometimes shared decision-making between patient and provider. Understanding which screenings are recommended at different ages, what each test involves, and how to prepare empowers women to take an active role in their preventive care. This guide provides a comprehensive overview of recommended health screenings for women and the evidence-based schedules that guide them.
Cervical Cancer Screening
Pap Smear
The Papanicolaou test, or Pap smear, collects cells from the cervix to detect precancerous and cancerous changes. It is one of the most successful cancer screening tests ever developed, reducing cervical cancer incidence and mortality by more than 70 percent since its introduction.
Current guidelines from the U.S. Preventive Services Task Force recommend: screening initiation at age twenty-one regardless of sexual history, Pap test alone every three years from ages twenty-one to twenty-nine, and for ages thirty to sixty-five, either Pap test alone every three years, HPV test alone every five years, or co-testing with Pap and HPV every five years. Women over sixty-five who have had adequate prior screening with normal results and are not at high risk can discontinue screening.
HPV Testing
HPV testing detects high-risk strains of human papillomavirus that cause essentially all cervical cancers. HPV testing may be used as primary screening starting at age thirty, or as co-testing with Pap. The advantage of HPV primary screening is its high negative predictive value — a negative HPV test provides longer reassurance than a negative Pap. HPV vaccination does not change screening recommendations; vaccinated women should follow the same screening schedule.
HPV Vaccination and Screening
HPV vaccination does not change screening recommendations. Vaccinated women should follow the same screening schedule as unvaccinated women because the vaccine does not protect against all high-risk HPV types. Discussing HPV vaccination with adolescents and young adults remains an important preventive health conversation. The quadrivalent and nonavalent vaccines prevent infection with HPV types 16 and 18, which cause approximately 70 percent of cervical cancers, but do not protect against the remaining high-risk types. Screening remains essential for detecting HPV-related precancers regardless of vaccination status.
Screening After Hysterectomy
Women who have had a total hysterectomy with cervical removal for benign reasons and have no history of cervical dysplasia or cancer do not need continued screening. Women with hysterectomy for cervical precancer or cancer should continue screening as recommended by their specialist.
Breast Cancer Screening
Mammography
Screening mammography reduces breast cancer mortality by 20 to 40 percent in women aged forty to seventy-four. As discussed in the Breast Health Guide, guidelines vary by organization. The American College of Radiology recommends annual mammography starting at age forty. The USPSTF recommends biennial mammography from ages forty to seventy-four, with the decision to start between forty and forty-nine being an individual one.
Supplemental Screening
Women with dense breast tissue, which affects approximately 40 percent of women, may benefit from supplemental screening with ultrasound or MRI in addition to mammography. Dense tissue reduces mammography sensitivity and is an independent risk factor for breast cancer. Many states require that women be notified if they have dense breasts on mammography. Breast MRI is recommended annually for women at high risk, including those with BRCA mutations, strong family history, or prior chest radiation.
Clinical Breast Exam
Clinical breast examination by a healthcare provider is no longer recommended as a screening tool. It is not effective for detecting early breast cancer and does not reduce mortality. Breast self-awareness — familiarity with your normal breast tissue — remains important.
Bone Density Screening
Dual-Energy X-Ray Absorptiometry
DXA scanning of the hip and spine is the standard method for diagnosing osteoporosis and assessing fracture risk. The USPSTF recommends screening for all women aged sixty-five and older. Screening should begin earlier, at age sixty or younger, for women with risk factors: low body weight, parental history of hip fracture, current smoking, excessive alcohol use, long-term glucocorticoid use, rheumatoid arthritis, and early menopause.
Screening Interval
The optimal screening interval depends on initial bone density. Women with normal bone density can safely wait ten to fifteen years before repeat screening. Those with osteopenia should repeat every one to five years depending on the T-score and presence of risk factors. The Fracture Risk Assessment Tool helps guide both initial screening decisions and treatment thresholds.
Colorectal Cancer Screening
Colorectal cancer screening is recommended for average-risk women starting at age forty-five. Screening methods include colonoscopy every ten years, flexible sigmoidoscopy every five years, CT colonography every five years, and stool-based tests including FIT annually or Cologuard every three years. Colonoscopy is the gold standard because it allows simultaneous detection and removal of precancerous polyps. Women at higher risk due to family history, inflammatory bowel disease, or hereditary syndromes should begin screening earlier and at more frequent intervals.
Lipid and Cardiovascular Screening
Blood cholesterol and triglyceride testing should begin at age twenty and be repeated every four to six years in low-risk women. Women with risk factors including diabetes, hypertension, obesity, smoking, or family history of premature heart disease should be screened more frequently. The pooled cohort equations estimate ten-year and lifetime risk of atherosclerotic cardiovascular disease and guide treatment decisions including statin therapy.
Blood Pressure Screening
Blood pressure should be screened at least annually in all women, and at every healthcare visit when possible. Hypertension is defined as blood pressure consistently above 130/80 mmHg. Home blood pressure monitoring is encouraged for women with elevated readings or white coat hypertension.
Diabetes Screening
Screening for type 2 diabetes with fasting glucose or HbA1c should begin at age thirty-five for overweight or obese women. Earlier and more frequent screening is recommended for women with risk factors including family history of diabetes, PCOS, history of gestational diabetes, or high-risk race and ethnicity.
Screening Schedule by Age
Ages 18 to 39
Pap smear starting at age twenty-one, every three years. Blood pressure screening annually. Cholesterol screening starting at age twenty, every four to six years. BMI assessment at well-woman visits. STI screening based on risk. Clinical breast exam is not recommended. Breast self-awareness is encouraged.
Ages 40 to 49
Mammography starting at age forty, annually or biennially depending on guideline. Continued Pap/HPV screening per guidelines. Blood pressure, cholesterol, and diabetes screening. Bone density screening if risk factors present.
Ages 50 to 64
Mammography continues annually or biennially. Colorectal cancer screening starting at age forty-five. Continued cervical cancer screening. Bone density screening if risk factors present. Continued cardiovascular screening.
Ages 65 and Older
Mammography continues through age seventy-four, and after that based on health status and life expectancy. Bone density screening for all women. Cervical cancer screening may discontinue after age sixty-five if adequate prior screening. Continued cardiovascular and diabetes screening.
Frequently Asked Questions
How often should I have a Pap smear? Ages twenty-one to twenty-nine: every three years. Ages thirty to sixty-five: every three to five years depending on testing method. Screening may stop after sixty-five with adequate prior normal screening.
Do I need a mammogram every year? The ACR recommends annual mammography starting at forty. The USPSTF recommends biennial screening. Discuss with your provider to make an informed decision based on your values and risk factors.
At what age should I get a bone density test? All women should be screened at age sixty-five. Earlier screening starting at age sixty may be appropriate for women with risk factors.
Can I get screened if I have no symptoms? Yes. Screening is for asymptomatic individuals. The purpose is to detect disease before symptoms develop, when treatment is most effective.
What if I have a family history of cancer? Family history may warrant earlier or more frequent screening. Inform your provider about any first-degree relatives with cancer, particularly at young ages.
Are there risks to screening? Screening carries risks of false positives leading to unnecessary additional testing and anxiety, false negatives providing false reassurance, and overdiagnosis of conditions that would never have caused symptoms.
How do I prepare for a mammogram? Do not use deodorant, antiperspirant, powder, or lotion on the day of the exam as these can appear as artifacts on images. Wear a two-piece outfit for convenience.
What is a well-woman visit? An annual preventive visit focused on health screening, risk assessment, and counseling. It may include Pap smear, clinical breast exam, pelvic exam, and discussion of contraception, fertility, and lifestyle.
Breast Health Guide — Bone Health for Women — Heart Health for Women — Contraception Guide — Reproductive Health Guide